Medicine & Life Sciences
Organized Financing
100%
Antineoplastic Protocols
92%
Neoplasms
70%
Clinical Protocols
63%
Multiple Myeloma
39%
Growth and Development
33%
Research Personnel
32%
Lymphoma, Large B-Cell, Diffuse
30%
Survival
28%
Occupational Groups
23%
Biostatistics
20%
Authorship
19%
Clinical Trials
18%
Therapeutics
16%
Thalidomide
16%
Patient Care
15%
Self-Help Groups
15%
Hematologic Neoplasms
15%
Manuscripts
15%
Rituximab
14%
Karyotype
13%
Quality of Health Care
13%
Cytogenetics
13%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13%
Population
12%
Treatment Failure
12%
Dexamethasone
12%
Methylation
12%
Leukemia
10%
Clinical Studies
9%
Morbidity
7%
Mortality
6%
Combined Modality Therapy
6%
Natural History
5%
Antineoplastic Agents
5%